THE SIGNAL

Andy Florance, founder and CEO of CoStar Group, bought 83,300 shares at $29.89 on August 4, spending $2.49 million of his own money. He already owned over 1.7 million shares. He bought the day after CoStar reported its 61st consecutive quarter of double-digit revenue growth, a 116% year-over-year jump in adjusted EBITDA, and the first-ever positive EBITDA from its residential segment. The stock sold off anyway.

The same week, Michael Maroone, director at Carvana, bought 25,000 shares at $61.80 for $1.54 million directly into a 7-15% post-earnings drop, even though Carvana had just printed record profitability, 38% unit growth, and net debt to EBITDA of 1.0x. Christopher Mahoney, director at Bunge Global, bought 6,500 shares totaling $689,050 in two tranches immediately after Bunge raised full-year guidance and reported adjusted EBITDA up 113% year-over-year, only to watch the stock fall 8%. And David Moreno, President of FTAI Aviation, bought 2,475 shares at $201.27 for $498,000 after FTAI's stock dropped 16-19% on an earnings "miss" that represented $953 million in revenue and 41% year-over-year growth.

Four different companies. Four different industries. One identical behavior: executives with the deepest possible knowledge of their own financials putting personal capital to work within 24-72 hours of market overreactions to strong quarters.

That is the signal worth decoding today.

THE INTERPRETATION

What the market does with earnings reports and what insiders see inside those same reports are two different things right now.

The pattern across these four trades reveals a specific and recurring gap. Markets are reacting to forward guidance trims, mix shifts, and single-quarter optics. Insiders are reading structural margin trajectories, contract durability, and competitive positioning that don't compress to a single EPS line.

Florance's buy is the most forensically revealing of the group. CoStar's quarter was objectively excellent by any multi-year standard. Revenue of $925 million, adjusted EBITDA of $184 million, and residential finally crossing into positive EBITDA territory for the first time. The selloff was triggered by a slightly softer forward revenue guide tied to deliberate choices: sales-force optimization, Ten-X restructuring, and pricing discipline. Florance, who built this company over three decades, is buying because he can see what Street analysts cannot: the margin inflection is real and accelerating, the residential investment is finally converting, and the guide trim is a product of intentional capital allocation, not demand weakness. He has now bought 127,150 shares over six months with zero sales. The corporate board has repurchased $587 million in shares year-to-date. Both the founder and the balance sheet are saying the same thing.

Maroone's Carvana buy carries a different kind of authority. He is a former major auto retail executive sitting on the board of the most efficient used-car operation ever built. When Carvana reported $7.38 billion in revenue, 197,325 retail units, $513 million in net income, and a 10.4% adjusted EBITDA margin, the market sold it because guidance came in slightly below the most aggressive bull-case estimates. Maroone, with visibility into funnel conversion data, financing economics through the recently amended $8 billion Ally facility, and unit-level profitability metrics, bought the pullback immediately. His message is specific: the guidance conservatism is strategic, the underlying machine is performing at record levels, and the selloff is a sentiment artifact.

Bunge's Mahoney brings commodity-cycle expertise that few analysts can match. As a director with deep commodities experience, he sees forward crush margins, Viterra integration milestones, and crop-cycle positioning that Street models approximate from public data. Bunge raised full-year adjusted EPS guidance and posted adjusted segment EBIT up 113%. The market sold it on "integration risk" and valuation anxiety. Mahoney stepped in with nearly $700,000 across two days. He is saying the synergies from Viterra are tangible and progressing, the earnings quality is better than the P/E optics suggest, and the cycle has more runway than consensus pricing reflects.

Moreno's FTAI buy is a time-arbitrage call dressed up as an earnings reaction trade. FTAI's stock dropped sharply because the company missed EPS estimates and cut aviation leasing EBITDA guidance. But the cut came from a deliberate strategic pivot: reallocating engine module capacity from internal leasing to external customers at higher margins. Module production was up 61% year-over-year. The $1.465 billion power contract is fully intact. As President, Moreno sees the actual margin profile on aerospace module contracts and knows whether the EBITDA miss is a structural deterioration or a timing-and-mix accounting artifact. He bought $498,000 worth of stock at $201. That is an answer.

THE EVIDENCE

The broader trade cluster this week reinforces the same theme from multiple angles.

Jersey Mike's Subs had its President and CFO both initiate positions at the IPO price on July 31. Peterson (President) bought $345,000 at $23.00, taking a fresh 15,000-share stake. Allen (CFO) bought $299,000 at $23.00. When the two executives most directly responsible for operating performance and financial health both buy at the IPO print with zero prior exposure, they are stating plainly that the current price does not reflect their view of the business's trajectory. CFOs in particular buy when they believe the market undervalues what they can see in the unit economics.

Jack Jiajia Huang, CEO of 51Talk, bought another 473,520 shares at $17.02 for $8.06 million on July 28. He has now spent over $137 million buying his own stock at an average price above $19, and he is still buying at $17. The stock is down 46-50% from its 52-week high. He has sold nothing. A founder-CEO who is underwater on a nine-figure personal accumulation program and continues buying is not expressing optimism. He is expressing certainty grounded in real-time visibility into bookings, retention, and cash generation that the market cannot see.

Durable Capital Partners added 36,256 shares of Goosehead Insurance at $61.92 for $2.24 million, bringing their stake to 2.57 million shares. Goosehead had just reported revenue up 21%, net income doubled, and adjusted EBITDA margins of 33%. The stock was still 30% below prior highs. Durable is a long-duration fundamental investor who has built a core position over time. Adding after a clear earnings beat while the stock trades at a discount to prior peaks says the growth durability is intact and the valuation compression is an opportunity, not a warning.

ADAR1 Capital, a specialized biotech fund with board-level access at NextCure, bought 329,153 shares at $4.93 after a reverse-merger announcement drove a 200% spike and then partial reversal. They averaged into the pullback rather than harvesting the gain. As a director, ADAR1 has direct knowledge of Avery Therapeutics' pipeline value, the pro-forma cash position, and deal terms. Buying into the post-spike consolidation at these levels means they believe the combined entity is being valued well below its asset and pipeline reality.

THE REALITY CHECK

The consistent insider signal across this week's trades is precise: earnings-driven selloffs in fundamentally sound businesses are being overcooked by markets anchored on short-term guidance trims and backward-looking EPS optics.

Four executives with the most direct possible access to their businesses' actual economics stepped in with personal capital within hours or days of adverse market reactions. None of them bought on momentum. All of them bought against fear.

The market's current operating assumption appears to be that any guidance conservatism signals peak conditions, that mix shifts confirm deterioration, and that post-earnings volatility reflects genuine fundamental change. Insiders with board-level or C-suite visibility are rejecting that assumption with their own money.

What they are collectively seeing across commercial real estate data, used-car markets, global agriculture, and aviation services is a version of the same reality: the underlying margin and cash flow trajectories are healthier than post-earnings reaction prices imply, and the forward guidance that spooked markets reflects deliberate strategic choices rather than demand deterioration.

For investors watching this cluster, the forensic read is straightforward. When a founder buys his own stock the day after his company's 61st consecutive double-digit growth quarter, when a board member with deep retail expertise buys a car company trading at record profitability margins after a guidance miss, when a commodities-expert director adds to a position after a guidance raise and a selloff, and when a company's own president buys after a capacity-strategy shift gets misread as weakness, the gap between market price and business reality has become wide enough that the people who know best are willing to document their conviction on a public SEC filing.

They are not timing a trade. They are correcting a mispricing.